MARKET

ORGO

ORGO

Organogenesis Holdings Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.85
+0.12
+2.09%
After Hours: 5.85 0 0.00% 16:00 09/19 EDT
OPEN
5.77
PREV CLOSE
5.73
HIGH
5.96
LOW
5.71
VOLUME
63.51K
TURNOVER
--
52 WEEK HIGH
310.90
52 WEEK LOW
3.560
MARKET CAP
226.69M
P/E (TTM)
-4.7288
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ORGO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ORGO News

  • Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2019 Financial Results on November 12, 2019
  • GlobeNewswire.2d ago
  • Daily Insider Ratings Round Up 9/13/19
  • Seeking Alpha - Article.3d ago
  • Daily Insider Ratings Round Up 9/10/19
  • Seeking Alpha - Article.09/12 23:53
  • 71 Biggest Movers From Yesterday
  • Benzinga.09/12 09:33

More

Industry

Pharmaceuticals
+0.52%
Pharmaceuticals & Medical Research
+0.41%

Hot Stocks

Name
Price
%Change

About ORGO

Organogenesis Holdings Inc., formerly Avista Healthcare Public Acquisition Corp, is a regenerative medicine company. The Company focuses on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. It also provides integrated healing solutions that substantially improve medical outcomes. The Company’s advanced wound care and surgical & sports medicine products include PuraPly, Antimicrobial (PuraPlyAM), PuraPly, Affinity, NuShield, Apligraf and Dermagraft. The Company is offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. The Company’s comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs.
More

Webull offers Organogenesis Holdings Inc (ORGO) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.